IKT R&D Expense Growth
Inhibikase Therapeutics Inc · R&D Expense Growth
IKT R&D Expense Growth
Latest reported73.11%period ending
IKT FY R&D Growth (YoY) (0.00% → 73.11%)
Latest values, visible window
High-resolution chart · PNG
IKT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 73.1098% | |
| 26.3776% | |
| 13.1563% | |
| 5.9501% | |
| 1,170.8748% | |
| -64.9862% | |
| -30.0073% | |
| 107.7305% | |
| 107.434% | |
| 0% |